International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Since Year 2012 | Open Access | Double Blind Reviewed

ISSN: 2319-7064

Downloads: 105

Research Paper | Pharmacology Science | Iraq | Volume 5 Issue 9, September 2016

Predicting Resistance to Recombinant Human Erythropoietin Therapy in CKD Patients on Maintenance Hemodialysis

Mohanad Yasir Al-Radeef | Sajida Hussein Ismail [3] | Ali Abdul-Majid Dyab Allawi

Abstract: Background Anemia is a common complication associated with chronic kidney disease (CKD), and optimal treatment requires appropriate diagnosis, recombinant human erythropoietin (rHuEPO) and iron therapy, and close monitoring of response. Approximately 5-10 % of these patients receiving rHuEPO therapy, however, appear to be hypo-responsive to this drug. This study aimed to identify some determinants of rHuEPO hypo-responsiveness in anemic CKD patients on maintenance hemodialysis. Method Seventy patients with CKD on maintenance hemodialysis receiving rHuEPO and (20) control subjects were enrolled in this case-control prospective study. Erythropoietin resistance index (ERI), calculated as the weekly weight-adjusted dose of rHuEPO divided by the hemoglobin level was determined to evaluate the doseresponse effect of rHuEPO therapy. Determinants of rHuEPO hypo-responsiveness were identified by univariate logistic regression analyses. Results Approximately half of patients were inadequately responded to rHuEPO therapy with an ERI value >0.0365 g/kg/week/g hemoglobin. Univariate analyses revealed that duration of dialysis (years), BMI and serum albumin were the most important determinants of rHuEPO hypo-responsiveness and an inverse relationship had been found between these determinants and ERI. Conclusion easily available clinical parameters and routine laboratory parameters can predict hypo-responsiveness to rHuEPO therapy in hemodialysis patients.

Keywords: CKD, Anemia, rHuEPO hypo-responsiveness, ERI

Edition: Volume 5 Issue 9, September 2016,

Pages: 1020 - 1026

How to Cite this Article?

Mohanad Yasir Al-Radeef, Sajida Hussein Ismail, Ali Abdul-Majid Dyab Allawi, "Predicting Resistance to Recombinant Human Erythropoietin Therapy in CKD Patients on Maintenance Hemodialysis", International Journal of Science and Research (IJSR), Volume 5 Issue 9, September 2016, pp. 1020-1026,

How to Share this Article?

Similar Articles with Keyword 'CKD'

Downloads: 0

Research Paper, Pharmacology Science, India, Volume 11 Issue 11, November 2022

Pages: 905 - 912

Acetyl-CoA Carboxylase 1 Up-Regulation and Skin Tumor Formation in a Skin Carcinogenesis Mouse Model are Suppressed by Withaferin A.

Sonu Sharma [2] | Shilpa Mamgain | Jyoti Gupta [5]

Share this Article

Downloads: 128

Case Studies, Pharmacology Science, India, Volume 8 Issue 2, February 2019

Pages: 915 - 916

Azathioprine Induced Septicemia and Pancytopenia

Ameez S Khan | Vidya V Nair | Dr. Ganesan M.

Share this Article